DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
01 2Dr. Reddy's Laboratories
02 12care4
03 3Abacus Medicine
04 1Alvogen
05 2Chemi SpA
06 1CinnaGen
07 1Juno Pharmaceuticals Pty Ltd
08 3Medartuum
09 22ORIFARM GROUP AS
10 1Omnia L?kemedel Ab
11 9Paranova Pharmaceuticals Ab
12 1Pharmascience Inc.
13 2Sandoz B2B
14 3Synthon Pharmaceuticals
15 3Teva Pharma Australia
16 22Teva Pharmaceutical Industries
17 12Viatris
18 2World Medicine
01 1FOR SOLUTION;SUBCUTANEOUS
02 1Glatiramer 20Mg 28 Joined The Parenteral Use
03 1Glatiramer 40Mg 12 Units Parenteral Use
04 2INJ
05 10INJECTABLE;SUBCUTANEOUS
06 1Injectable
07 4Injectable Solution In Pre-Filled Syringe
08 2Injection
09 3Injection fluid, resolution in the finished filled syringe
10 1PFP
11 1Pre-filled Syringe
12 1Prefilled Syringe
13 4SOLUTION
14 2SOLUTION FOR INJECTION
15 50Solution For Injection
16 3Solution For Injection In Pre-Filled
17 3injection
18 1Blank
01 5Allowed
02 16Approved
03 4Authorized
04 1DISCN
05 28Deregistered
06 2Generic
07 2Lead Market Dossiers- Filed
08 1Originator
09 4Prescription
10 10RX
11 18Blank
01 7COPAXONE
02 2COPAXONE 20 mg/ml
03 1COPAXONE 40 mg/ml
04 1COPEMYL
05 1COPEMYLTRI
06 1CinnoMer
07 52Copaxone
08 1Copaxone Pen
09 1Copemyl
10 1GLATECT
11 6GLATIRAMER ACETATE
12 1GLATIRAMER ACETATE INJECTION
13 1GLATIRAMER ACETATE-TEVA
14 2GLATOPA
15 2Glatimyl
16 1Glatira
17 2Glatiramero Viatris
18 2Glatiramyl
19 2ROGRESIF/GLATIRAMER
20 1RemurelTM
21 3Blank
01 4Australia
02 4Canada
03 2India
04 1Iran
05 6Italy
06 1Netherlands
07 3Norway
08 3South Africa
09 4Spain
10 44Sweden
11 5Switzerland
12 2Turkey
13 1U.S.A
14 11USA
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : Lead Market Dossiers- Filed
Registration Country : India
Brand Name :
Dosage Form : Injection
Dosage Strength : 20MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : Lead Market Dossiers- Filed
Registration Country : India
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : Lead Market Dossiers- Filed
Registration Country : India
Brand Name :
Dosage Form : Injection
Dosage Strength : 40MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : Lead Market Dossiers- Filed
Registration Country : India
Regulatory Info : RX
Registration Country : USA
Brand Name : GLATIRAMER ACETATE
Dosage Form : INJECTABLE;SUBCUTANEOUS
Dosage Strength : 20MG/ML
Packaging :
Approval Date : 2025-05-07
Application Number : 208468
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : GLATIRAMER ACETATE
Dosage Form : INJECTABLE;SUBCUTANEOUS
Dosage Strength : 40MG/ML
Packaging :
Approval Date : 2025-05-07
Application Number : 208468
Regulatory Info : RX
Registration Country : USA
Regulatory Info :
Registration Country : Iran
Brand Name : CinnoMer
Dosage Form : Injectable
Dosage Strength : 40MG
Packaging : PFS
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Iran
Regulatory Info : RX
Registration Country : USA
Brand Name : GLATOPA
Dosage Form : INJECTABLE;SUBCUTANEOUS
Dosage Strength : 20MG/ML
Packaging :
Approval Date : 2015-04-16
Application Number : 90218
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : GLATOPA
Dosage Form : INJECTABLE;SUBCUTANEOUS
Dosage Strength : 40MG/ML
Packaging :
Approval Date : 2018-02-12
Application Number : 206921
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : GLATIRAMER ACETATE
Dosage Form : INJECTABLE;SUBCUTANEOUS
Dosage Strength : 20MG/ML
Packaging :
Approval Date : 2024-09-25
Application Number : 203857
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : GLATIRAMER ACETATE
Dosage Form : INJECTABLE;SUBCUTANEOUS
Dosage Strength : 40MG/ML
Packaging :
Approval Date : 2024-09-25
Application Number : 206873
Regulatory Info : RX
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : COPAXONE
Dosage Form : FOR SOLUTION;SUBCUTANEOUS
Dosage Strength : 20MG/VIAL
Packaging :
Approval Date : 1996-12-20
Application Number : 20622
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : COPAXONE
Dosage Form : INJECTABLE;SUBCUTANEOUS
Dosage Strength : 20MG/ML
Packaging :
Approval Date : 2002-02-12
Application Number : 20622
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : COPAXONE
Dosage Form : INJECTABLE;SUBCUTANEOUS
Dosage Strength : 40MG/ML
Packaging :
Approval Date : 2014-01-28
Application Number : 20622
Regulatory Info : RX
Registration Country : USA
Regulatory Info :
Registration Country : Italy
Brand Name : Copaxone
Dosage Form : Glatiramer 20Mg 28 Joined The Parenteral Use
Dosage Strength : 28 SYRINGES SC 20 mg/ml 1 ml
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Italy
Regulatory Info :
Registration Country : Italy
Brand Name : Copaxone
Dosage Form : Glatiramer 40Mg 12 Units Parenteral Use
Dosage Strength : 12 SYRINGES SC 40 mg/ml 1 ml
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Italy
Regulatory Info :
Registration Country : Norway
Brand Name : Copaxone
Dosage Form : Injection fluid, resolution in the finished filled syringe
Dosage Strength : 20 mg/ml
Packaging : Finish filled syringe
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Norway
Regulatory Info :
Registration Country : Norway
Brand Name : Copaxone
Dosage Form : Injection fluid, resolution in the finished filled syringe
Dosage Strength : 40 mg/ml
Packaging : Finish filled syringe
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Norway
Regulatory Info : RX
Registration Country : USA
Brand Name : GLATIRAMER ACETATE
Dosage Form : INJECTABLE;SUBCUTANEOUS
Dosage Strength : 20MG/ML
Packaging :
Approval Date : 2017-10-03
Application Number : 91646
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : GLATIRAMER ACETATE
Dosage Form : INJECTABLE;SUBCUTANEOUS
Dosage Strength : 40MG/ML
Packaging :
Approval Date : 2017-10-03
Application Number : 206936
Regulatory Info : RX
Registration Country : USA
Regulatory Info :
Registration Country : Norway
Brand Name : Copemyl
Dosage Form : Injection fluid, resolution in the finished filled syringe
Dosage Strength : 20 mg/ml
Packaging : Finish filled syringe
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Norway
Regulatory Info :
Registration Country : Turkey
Brand Name : ROGRESIF/GLATIRAMER
Dosage Form : SOLUTION FOR INJECTION
Dosage Strength : 20MG/ML
Packaging : 28 or 12 PRE-FILLED SYRINGE
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Turkey
